Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003854 · ClinicalTrials.gov registry record · Phase 3
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,590
- Enrollment target
NCT00003854 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 4,590 participants.
The verdict
NCT00003854, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,590 participants
- Enrollment target
Study Summary
RATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer. PURPOSE: Phase III prognostic study of sentinel lymph node metastases and bone marrow metastases in women who have stage I or stage IIA breast cancer.
Interventions
- OTHER immunohistochemistry staining method
- PROCEDURE therapeutic conventional surgery
- RADIATION whole breast irradiation
- PROCEDURE lymphangiography
- PROCEDURE sentinel lymph node biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,590 participants |
| Start Date | 1999-04 |
| Est. Completion | 2011-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003854
The ClinicalTrials.gov registry entry for NCT00003854 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 4,590 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which immunohistochemistry staining method is the first listed.
NCT00003854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003854 about?
NCT00003854 is a clinical study titled "Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer". RATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer. PURPOSE: Phase III prognostic study of sentinel lymph node metastases and bone marrow metastases in women who have stage I or stage IIA breast cancer.
What is the current status of trial NCT00003854?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,590 participants. The study started on 1999-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00003854?
The interventions under investigation include: immunohistochemistry staining method (OTHER), therapeutic conventional surgery (PROCEDURE), whole breast irradiation (RADIATION), lymphangiography (PROCEDURE), sentinel lymph node biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00003854?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.